TD Cowen Downgrades Cardiff Oncology (CRDF) to Hold

June 1, 2026 6:14 AM

TD Cowen analyst Marc Frahm downgraded Cardiff Oncology (NASDAQ: CRDF) from Buy to Hold.The analyst comments "Cardiff disclosed that onvansertib’s ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found